ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

ClinicalTrials.gov ID: NCT02475681

Public ClinicalTrials.gov record NCT02475681. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination With Chlorambucil, Acalabrutinib (ACP-196) in Combination With Obinutuzumab, and Acalabrutinib Monotherapy in Subjects With Previously Untreated CLL

Study identification

NCT ID
NCT02475681
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Acerta Pharma BV
Industry
Enrollment
535 participants

Conditions and interventions

Interventions

  • Acalabrutinib Drug
  • Chlorambucil Drug
  • Obinutuzumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 25, 2015
Primary completion
Feb 7, 2019
Completion
Sep 29, 2025
Last update posted
Aug 26, 2025

2015 – 2025

United States locations

U.S. sites
51
U.S. states
22
U.S. cities
47
Facility City State ZIP Site status
Research Site Goodyear Arizona 85395
Research Site Phoenix Arizona 85016
Research Site Anaheim California 92801
Research Site Los Angeles California 90017
Research Site Los Angeles California 90033
Research Site Los Angeles California 90095
Research Site Oxnard California 93030
Research Site Palo Alto California 94304
Research Site Aurora Colorado 80045
Research Site Lone Tree Colorado 80124
Research Site Washington D.C. District of Columbia 20007
Research Site Fort Myers Florida 33901-8101
Research Site Jacksonville Florida 32224
Research Site Tallahassee Florida 32308-5304
Research Site Tallahassee Florida 32308
Research Site Tampa Florida 33612
Research Site Niles Illinois 60714
Research Site Lafayette Indiana 47904
Research Site Wichita Kansas 67214
Research Site Louisville Kentucky 40207
Research Site New Orleans Louisiana 70112
Research Site COL Maryland 21044
Research Site Rochester Minnesota 55905
Research Site Saint Cloud Minnesota 56303
Research Site Billings Montana 59102
Research Site Brick New Jersey 08724
Research Site Hackensack New Jersey ?07601
Research Site Lake Success New York 11042
Research Site New York New York 10029
Research Site Blue Ash Ohio 45242
Research Site Canton Ohio 44719
Research Site Columbus Ohio 43210
Research Site Nashville Tennessee 37203
Research Site Austin Texas 78705
Research Site Bedford Texas 76022
Research Site Dallas Texas 75230
Research Site Fort Sam Houston Texas 78234
Research Site Houston Texas 77030
Research Site New Braunfels Texas 78130
Research Site Round Rock Texas 76508
Research Site San Antonio Texas 78258
Research Site Texas City Texas 77591
Research Site Tyler Texas 75702
Research Site Salt Lake City Utah 84112
Research Site Roanoke Virginia 24014
Research Site Seattle Washington 98109
Research Site Seattle Washington 98122
Research Site Spokane Washington 99208
Research Site Tacoma Washington 98405
Research Site Yakima Washington 98902
Research Site Northwest WA Wisconsin 20007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02475681, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2025 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02475681 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →